Dow Venture Capital

corporate.dow.com/en-us/collaborations/venture-capital.html

Foreign Corporate VC

Tech Verticals Preferences

Biotechnology AgriBiotech, AgriTech, Bio Energy, Biochemichals, Energy Tech, Environment, Hardware, Manufacturing, Materials, Medical Devices, MedTech, Oil, Petrochemicals, Pharmaceuticals, Software Technologies, WaterTech

General Data

Established	1993
Current Active Portfolio Companies:	1

DESCRIPTION

Dow Venture Capital provides capital and other developmental resources to start-up companies that meet its investment objectives. The company has investments in venture funds through more than 10 institutional venture capital firms and collaborates globally with an even broader network of venture partners. Dow Venture Capital is focused on pursuing strategic investments that enable and accelerate Dow’s business growth while adding value to its portfolio companies.

The investment portfolio of Dow Venture Capital reflects the diversity of Dow's business interests, with start-up companies in various stages of maturity across a broad set of markets. The company invests in promising businesses and technologies that help address many of the world’s most challenging problems, such as the need for clean water, renewable energy generation and conservation, and increasing agricultural productivity.

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
		DowDuPont Inc
D5A5DB50-207A-E111-AC59-00155D32A403	Investment Arm	Dow Venture Capital	DowDuPont Inc

CONTACT INFO

Expand / Collapse All

Main Address: Midland, United States

Address	2030 Dow Ctr.
City	Midland
State/Province	MI
Country	United States
Zip	48674

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Horgen, Switzerland

Address	Bachtobelstrasse 3
City	Horgen
Country	Switzerland
Zip	8810

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Mark Felix	Investment Manager

Investment Data

Managed Capital

abCDe

Preferences

Maximum investments	$5m
Minimum investments	$0.2m
Type of Financing	Equity,Investments in Funds
Stage Preferences	Initial Revenues,R&D,Revenue Growth,Seed
Phase Preferences	Clinical Trials,Discovery,Phase I,Phase II,Phase III,Pre Clinical

	PORTFOLIO COMPANIES

Current Portfolio Companies (1)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

ATC (now Rotem Ventues)

N/A

Other	01/06/2003	N/A	N/A
Other	01/06/2000	N/A	N/A

Current VC Fund Portfolio (5)

Fund Name

Fund Type

Date Announced

Amount

Remarks

Eucalyptus Ventures

Venture Capital Fund

01/01/1997

N/A

Investment made by Dow Chemicals

Pitango III

Venture Capital Fund

01/01/2000

N/A

CVC of Dow Chemical Company

Pitango IV

Venture Capital Fund

01/01/2004

N/A

CVC of Dow Chemical Company

Pitango V

Venture Capital Fund

01/01/2007

N/A

CVC of Dow Chemical Company

Pitango VI

Venture Capital Fund

02/09/2012

N/A

Exits (6)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij (Other)	Holdings Sold		abCDe
abC Defghij	Acquired	26/11/2006	abCDe	In shares.
abC Defghij	Acquired	29/04/2007	abCDe
abC Defghij	Acquired	20/04/2002	abCDe
abC Defghij	Acquired	17/06/2007	abCDe	$28m in cash
abC Defghij (Incubator)	Holdings Sold		abCDe

Historic Portfolio (2)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Eucalyptus

N/A

Investment in Fund

01/01/1997

N/A

Yozmot HaEmek

Ceased to Operate

N/A

Investment in Fund

01/01/2003

N/A

Last Updated:	abCDe
IVC Number:	abCDe